Patients with sleep apnea receiving pulmonary rehabilitation had 34% lower all-cause mortality than similar patients who did not receive PR.

Analysts expect a negative impact on ResMed Inc. (RMD) after privately held pharmaceutical company and rival Apnimed, Inc.

Let's see what has spooked investors today and caused them to push the sell button. The post Down 5%: What's going on with ...

A Cedar Rapids-based ear, nose and throat surgeon is among the first in the country – and the only in the Midwest – to offer ...

Late-breaking findings on pulmonology, critical care, and sleep medicine will be presented at the American Thoracic Society (ATS) 2025 International Conference.

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

He emphasized the upcoming acquisition of Sleep Center of Nevada (SCN), calling it "transformational" and forecasting it as a "total game changer for Vivos." Huntsman said the transaction is expected ...

Incannex Healthcare Inc IXHL +854.6% + Free Alerts shares surged 876% to 83 cents on Wednesday after the company announced ...

The U.S. Court of Appeals for the Eleventh Circuit has concluded that a successful False Claims Act (FCA) claim should “allege not just a scheme, ...

Is NiteHush Pro the actual solution to snoring you’ve been looking? Read my reviews for firsthand results, pros & cons, and ...

In its first letter of the year to its ranks, the CPIM has called for the formation of grassroots-level “alternative” schools, tuition centres, and health camps to reach out to the people of West ...